Expanded Access Guidance On COVID-19 Will Inform US FDA’s Post-Pandemic Policies

 
• By Sue Sutter
  
Stand out of a crowd - individuality
US FDA is giving advice to IRBs on how to handle individual patient expanded access requests. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D